XORTX Therapeutics Correlations

XRTX Stock

USD 1.03 0.02 1.98%

The current 90-days correlation between XORTX Therapeutics and Quoin Pharmaceuticals Ltd is -0.03 (i.e., Good diversification). The correlation of XORTX Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

XORTX Therapeutics Correlation With Market

Good diversification

The correlation between XORTX Therapeutics and DJI is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding XORTX Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

Moving together with XORTX Stock

0.82	EYEN	Eyenovia	Pair Corr
0.61	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.7	SGHT	Sight Sciences	Pair Corr

Moving against XORTX Stock

0.71	FNA	Paragon 28	Pair Corr
0.53	OPT	Opthea	Pair Corr
0.51	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.33	RGEN	Repligen Potential Growth	Pair Corr
0.32	CMRX	Chimerix Sell-off Trend	Pair Corr
0.77	NVRO	Nevro Corp	Pair Corr
0.59	INMD	InMode	Pair Corr
0.56	NYXH	Nyxoah	Pair Corr
0.51	LUCD	Lucid Diagnostics Buyout Trend	Pair Corr
0.46	NPCE	Neuropace	Pair Corr
0.34	MASI	Masimo	Pair Corr
0.73	TOI	Oncology Institute Earnings Call This Week	Pair Corr
0.7	TMCI	Treace Medical Concepts	Pair Corr
0.62	SWZNF	Schweizerische Nationalbank	Pair Corr
0.56	FWEDF	Fireweed Zinc	Pair Corr
0.48	BRK-A	Berkshire Hathaway	Pair Corr
0.48	BRK-B	Berkshire Hathaway	Pair Corr

Related Correlations Analysis

	CNTX	NRSN	BTTX	QNRX	ENSC
CNTX		0.4	0.0	0.6	0.86	CNTX
NRSN	0.4		0.0	0.05	0.44	NRSN
BTTX	0.0	0.0		0.0	0.0	BTTX
QNRX	0.6	0.05	0.0		0.42	QNRX
ENSC	0.86	0.44	0.0	0.42		ENSC
	CNTX	NRSN	BTTX	QNRX	ENSC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ENSC	+ 0.86	CNTX
QNRX	+ 0.6	CNTX
ENSC	+ 0.44	NRSN
ENSC	+ 0.42	QNRX
NRSN	+ 0.4	CNTX
QNRX	+ 0.05	NRSN

High negative correlations

ENSC	- 0.0	BTTX
QNRX	- 0.0	BTTX
BTTX	- 0.0	NRSN
BTTX	- 0.0	CNTX

Risk-Adjusted Indicators

There is a big difference between XORTX Stock performing well and XORTX Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze XORTX Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
CNTX	4.74	(0.21)	(2.16)	13.33	(6.74)	28.09
NRSN	2.45	(0.26)	1.82	4.76	(5.08)	14.14
BTTX	0.00	0.00	0.00	0.00	0.00	0.00
QNRX	5.47	(1.11)	2.34	14.29	(10.53)	57.78
ENSC	3.91	(1.16)	(0.90)	9.57	(6.21)	35.30

XORTX Therapeutics Corporate Management

MD MBA	Chief Officer	Profile
MBA DVM	Chief Officer	Profile
Charlotte May	Corporate Secretary	Profile
MRCP MD	Chief Officer	Profile
David MacDonald	Consultant Operations	Profile
Nick Rigopoulos	Director Communications	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC